US36338D1081 - Common Stock
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!
Get insights into the top gainers and losers of Wednesday's after-hours session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!
GRTX stock results show that Galera Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Company continues to evaluate strategic options to maximize shareholder value
Company continues to evaluate strategic options to maximize shareholder value...
The biggest pre-market stock movers for Wednesday are ready to go as we break down all of the latest news moving shares today!
Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!
FDA confirms need for new trial for avasopasem; GRECO trials with rucosopasem to be discontinued Company evaluating potential strategic options to...
Galera Therapeutics (GRTX) plunges after announcing that the company will be forced to discontinue operations if it fails to find strategic alternatives. Read more here.
FDA confirms need for new trial for avasopasem for severe oral mucositis (SOM) GRECO-2 trial did not pass futility analysis; Company will discontinue both...